Drug
Zp8396
Zp8396: highest development phase Phase 1, developed by Zealand Pharma. 2 trial records tracked on RxWires.
- Highest phase
- Phase 1
- Developer
- Zealand Pharma
Trials
| Drug | Phase | Indication |
|---|---|---|
| ZP8396 NCT05613387 | Phase 1 | Overweight |
| ZP8396 NCT05096598 | Phase 1 | Overweight |
Latest
No recent events.
Follow Zp8396 on RxWires to get trial status changes, FDA actions, filings and patent dates as they happen.
Sourced from ClinicalTrials.gov, openFDA, SEC EDGAR and the FDA Orange Book. Not investment or medical advice.